Article 1TYPS Shingles vaccine candidate shows high efficacy in adults 70 and older

Shingles vaccine candidate shows high efficacy in adults 70 and older

by
Press Release
from Outbreak News Today on (#1TYPS)
GlaxoSmithKline (GSK) announced the publication of detailed results from a randomized phase III study (ZOE-70) of its investigational shingles vaccine, showing 90% efficacy in adults aged 70 years and older that is maintained for at least four years. The results were published in the New England Journal of Medicine (NEJM). The study, from which headline results ["]OutbreakNewsToday?d=yIl2AUoC8zA OutbreakNewsToday?d=qj6IDK7rITs
External Content
Source RSS or Atom Feed
Feed Location http://feeds.feedburner.com/OutbreakNewsToday
Feed Title Outbreak News Today
Feed Link https://outbreaknewstoday.com/
Feed Copyright The Global Dispatch, Inc
Reply 0 comments